Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities [PDF]
, 2016 Bortezomib-based induction therapies have shown to increase complete response rates and are used as an upfront therapy for newly diagnosed multiple myeloma patients.
Lee, Saem
core +1 more source
Risk of Multiple Myeloma In Rheumatoid Arthritis: A Meta-Analysis of Case-Control and Cohort Studies
, 2014 Multiple myeloma is a malignant neoplasm of plasma cells mainly affecting elderly patients. Despite the wealth of information available on therapeutic strategies, the etiology and pathogenesis of myeloma remain unclear.
Li, Jian +4 more
core +3 more sources
Modeling the Effects of Multiple Myeloma on Kidney Function
, 2018 Multiple myeloma (MM), a plasma cell cancer, is associated with many health challenges, including damage to the kidney by tubulointerstitial fibrosis.
Ayati, Bruce P. +2 more
core
Teclistamab-Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma. [PDF]
EJHaemQuevedo-Salazar R +6 more
europepmc +1 more source
Mechanisms of action and clinical development of elotuzumab [PDF]
, 2017 Colonna, Marco, Ritchie, David
core +2 more sources
Wells' Syndrome Mimicking Angioedema and Revealing a Multiple Myeloma: A Case Report. [PDF]
CureusMansour Billah L, Chiheb S, Eljazouly M.
europepmc +1 more source
Erratum: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance. [PDF]
Am J Cancer ResWang Y +7 more
europepmc +1 more source
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities. [PDF]
EJHaemPatel A +13 more
europepmc +1 more source
The significance of RB1 in multiple myeloma. [PDF]
Front ImmunolWang Y +5 more
europepmc +1 more source